Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Recent findings illuminate research in cervical cancer
February 8th, 2006
Investigators in the United Kingdom, rtsimoes@rge and castlep@mail have published new cervical cancer data. Study 1: Human papillomavirus-16 immunity is significantly different during progressive cervical intraepithelial neoplasia. According to recent research published in the British Journal of Cancer, "Infection with high-risk genital human papillomavirus (HPV) types is a major risk factor for the development of cervical intraepithelial neoplasia (CIN) and invasive cervical carcinoma." "The design of effective immunotherapies requires a greater understanding of how HPV-specific T-cell responses are involved in disease...
Source: Immunotherapy Weekly (2006-02-08)
|
